Rob Morgan, Managing Partner, Medical
Rob gives a brief introduction to his role at Sagentia Innovation and our work with MedTech and Pharma companies...
FDA IVD review process has changed; how should manufacturers adapt?
A surge in premarket submissions during Covid-19 led the FDA to realign its review process for IVDs. Consequently, many...
The future of tissue sample preparation for cancer diagnosis
Cancer is the second leading cause of mortality worldwide, accounting for around 1 in 6 deaths globally, yet survival...
Microfluidics – designing in the lowest cost
You’ve developed a new assay. After considerable effort, resource and investment, it’s been shown in the lab to be...
Webinar: Automating FFPE sample preparation for faster diagnostics and greater accessibility
Recently Nick Collier, Sagentia Medical CTO has been considering how easy to use cartridge-based instruments could be...
Improving dialysis in the home
By Chris Humby, Vice-President Medical at Sagentia Statistics surrounding chronic kidney disease (CKD) make sobering...
Harnessing AI to boost the fight against hospital-acquired sepsis
One in five global deaths are related to sepsis, and many cases are linked to hospitalization and medical devices...
Transforming dentistry
Dentistry has a long history of reinventing and repurposing technologies from other branches of medicine. In the...
World-class research laboratories & facilities
Did you know Sagentia owns 100,000 sq ft of dedicated research and development facilities? This R&D real estate...
The challenges of developing ultra-sensitive diagnostic assays
Nick Collier, Ph.D. describes the technical hurdles behind designing the next generation of in vitro diagnostic...
